Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer

Abstract The development of metastasis is a leading cause of cancer-related death that involves specific changes in the plasma membrane (PM) and nucleus of cancer cells. Elevated levels of membrane lipids, including sphingomyelin, cholesterol, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), i...

Full description

Saved in:
Bibliographic Details
Main Authors: Agnieszka Chytła, Stephanie Rattay, Baki Akgül, Martin Sztacho
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-025-02452-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861642940645376
author Agnieszka Chytła
Stephanie Rattay
Baki Akgül
Martin Sztacho
author_facet Agnieszka Chytła
Stephanie Rattay
Baki Akgül
Martin Sztacho
author_sort Agnieszka Chytła
collection DOAJ
description Abstract The development of metastasis is a leading cause of cancer-related death that involves specific changes in the plasma membrane (PM) and nucleus of cancer cells. Elevated levels of membrane lipids, including sphingomyelin, cholesterol, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), in the PM, contribute to changes in membrane rigidity, lipid raft formation, and actin polymerisation dynamics, processes that drive cell invasion. This review discusses the relationship between well-studied cytoplasmic phosphoinositides and their lesser-known nuclear counterparts, highlighting their functional role in metastatic progression. Nuclear phosphoinositides, particularly PI(4,5)P2, are essential for regulating transcription factors and chromatin organisation, thereby shaping gene expression patterns. We also explore the role of PI(4,5)P2 and its metabolism in cancer cell invasiveness and metastasis, proposing a model in which the dysregulation of cytosolic and/or nuclear PI(4,5)P2 pool triggers malignant transformation. Understanding the PI(4,5)P2-related mechanisms underlying metastasis may provide insights into potential therapeutic targets, paving the way for more effective therapies and improved patient outcomes.
format Article
id doaj-art-66c8d82944e447bf832d8a742f9c7a9d
institution Kabale University
issn 1476-511X
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj-art-66c8d82944e447bf832d8a742f9c7a9d2025-02-09T12:52:36ZengBMCLipids in Health and Disease1476-511X2025-02-0124111110.1186/s12944-025-02452-6Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancerAgnieszka Chytła0Stephanie Rattay1Baki Akgül2Martin Sztacho3Laboratory of Cancer Cell Architecture, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles UniversityInstitute of Virology, Medical Faculty, University of Cologne, University Hospital CologneInstitute of Virology, Medical Faculty, University of Cologne, University Hospital CologneLaboratory of Cancer Cell Architecture, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles UniversityAbstract The development of metastasis is a leading cause of cancer-related death that involves specific changes in the plasma membrane (PM) and nucleus of cancer cells. Elevated levels of membrane lipids, including sphingomyelin, cholesterol, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), in the PM, contribute to changes in membrane rigidity, lipid raft formation, and actin polymerisation dynamics, processes that drive cell invasion. This review discusses the relationship between well-studied cytoplasmic phosphoinositides and their lesser-known nuclear counterparts, highlighting their functional role in metastatic progression. Nuclear phosphoinositides, particularly PI(4,5)P2, are essential for regulating transcription factors and chromatin organisation, thereby shaping gene expression patterns. We also explore the role of PI(4,5)P2 and its metabolism in cancer cell invasiveness and metastasis, proposing a model in which the dysregulation of cytosolic and/or nuclear PI(4,5)P2 pool triggers malignant transformation. Understanding the PI(4,5)P2-related mechanisms underlying metastasis may provide insights into potential therapeutic targets, paving the way for more effective therapies and improved patient outcomes.https://doi.org/10.1186/s12944-025-02452-6Phosphatidylinositol 4,5-bisphosphateNucleusBiocondensatesCancerMetastasisHPV
spellingShingle Agnieszka Chytła
Stephanie Rattay
Baki Akgül
Martin Sztacho
Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
Lipids in Health and Disease
Phosphatidylinositol 4,5-bisphosphate
Nucleus
Biocondensates
Cancer
Metastasis
HPV
title Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
title_full Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
title_fullStr Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
title_full_unstemmed Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
title_short Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
title_sort plasma membrane and nuclear phosphatidylinositol 4 5 bisphosphate signalling in cancer
topic Phosphatidylinositol 4,5-bisphosphate
Nucleus
Biocondensates
Cancer
Metastasis
HPV
url https://doi.org/10.1186/s12944-025-02452-6
work_keys_str_mv AT agnieszkachytła plasmamembraneandnuclearphosphatidylinositol45bisphosphatesignallingincancer
AT stephanierattay plasmamembraneandnuclearphosphatidylinositol45bisphosphatesignallingincancer
AT bakiakgul plasmamembraneandnuclearphosphatidylinositol45bisphosphatesignallingincancer
AT martinsztacho plasmamembraneandnuclearphosphatidylinositol45bisphosphatesignallingincancer